NovaGo Therapeutics: Funding, Investors & Team (Sep 2026)
NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke,
NovaGo Therapeutics has raised $29.7M across 1 funding round on record, the most recent a Series B of $29.7M announced in Aug 2026.
That round is above the $3.8M median round size for Switzerland companies tracked on FundedIQ over the last two years.
NovaGo Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2026.
NovaGo Therapeutics Funding Rounds
NovaGo Therapeutics Investors
NovaGo Therapeutics Founders and Leadership Team
Contact details for the NovaGo Therapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →NovaGo Therapeutics Funding in Context
NovaGo Therapeutics' latest round of $29.7M is above the median round in Switzerland. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NovaGo Therapeutics in Biotechnology and Schlieren
Companies Similar to NovaGo Therapeutics
Boulevard Bio is a biotechnology company founded by Deerfield Management that develops novel therapies for…
Mentari Therapeutics is a biotechnology company developing therapies for the prevention of migraine.
Syngenis Labs is committed to helping businesses and research organizations with their diagnostic and…
xorlab is a Swiss cybersecurity company providing specialized, machine-intelligent defense against highly…
Founded in Switzerland by Julian Liniger and Adem Bilican after they struggled to find a safe, hassle-free…
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
Gravis Robotics develops autonomous technology that retrofits construction machines for earthmoving and…
Supercharging asset managers with predictive AI
Vaderis Therapeutics is a clinical-stage biotechnology company developing targeted therapies for rare…
Navifare is an AI travel price optimization platform that compares flight, hotel, and car rental prices from…
Exclaim Robotics develops robots to maintain AI data centers.
At SUIND, our goal is to utilize advanced technology to enhance the productivity and ecological impact of…
NovaGo Therapeutics Funding FAQs
What does NovaGo Therapeutics do?
NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke,
How much funding has NovaGo Therapeutics raised?
NovaGo Therapeutics has raised $29.7M across 1 round on record. The most recent is a Series B of $29.7M announced in Aug 2026.
When did NovaGo Therapeutics last raise funding?
NovaGo Therapeutics' most recent funding round on record is a Series B of $29.7M, announced in Aug 2026.
Who has invested in NovaGo Therapeutics?
Investors on record for NovaGo Therapeutics include Swiss Paraplegic Foundation, Neurimmune Holding, Pureos Bioventures, Kinled Holding, Wings for Life.
Where is NovaGo Therapeutics headquartered?
NovaGo Therapeutics is based in Schlieren, Switzerland.
How many employees does NovaGo Therapeutics have?
NovaGo Therapeutics is in the 1-10 employee band.
When was NovaGo Therapeutics founded?
NovaGo Therapeutics was founded in 2015.
About FundedIQ's NovaGo Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NovaGo Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.